SL52136: The molecular biology of cancer
[Page last updated: 15 August 2024]
Academic Year: | 2024/25 |
Owning Department/School: | Department of Life Sciences |
Credits: | 5 [equivalent to 10 CATS credits] |
Notional Study Hours: | 100 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | EXOB 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | Students are expected to have a basic understanding of the biology basis and genetic mutations leading to cancer, and the concept of chemotherapy. |
Learning Outcomes: |
On successful completion of this unit, the student should be able to:
Synthesise an in-depth knowledge and understanding of the disease process in cancer and the complexity of its treatment.
Utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to complex, incomplete or contradictory situations. |
Synopsis: | In this unit you will explore advances in molecular and cellular processes underlying tumour development and its treatment. You will also develop your knowledge and understanding of the disease process in cancer, and the complexity of its treatment, and see examples of current treatment regimes in particular clinical settings. |
Content: | The cell and molecular biology driving tumour initiation and progression including tumour suppressor mechanisms and failure in apoptosis
epigenetic changes
activation of oncogenes
angiogenic processes and metastasis
cancer stem cells and cancer immunology
The molecular mechanisms of action of the major classes of drugs currently in use and their shortcomings, including chemotherapies, targeted therapies, and novel targets. |
Course availability: |
SL52136 is Optional on the following courses:Department of Life Sciences
|
Notes:
|